| Filed On | Filing |
|---|---|
| 02 Jul 2025 |
Form 4/A: Cabell Christopher, President & Head of R&D
Granted 1,100,705 Stock Option (Right to Buy) |
| 02 Jul 2025 |
Form 4/A: Iwicki Mark T, Director
Granted 602,346 Stock Option (Right to Buy) |
| 02 Jul 2025 |
Form 4/A: Aurentz Vincent, Director
Granted 134,427 Stock Option (Right to Buy) |
| 19 Feb 2025 |
Form 4/A: Berman Dennis N, Director
Granted 68,968 Stock Option (Right to Buy) |
Loading...
